Global Obesity Clinical Trial Pipeline Highlights Report 2019 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global
Obesity Clinical Trial Pipeline Highlights – 2019” report has
been added to ResearchAndMarkets.com’s offering.

Obesity Pipeline Highlights – 2019, provides most up-to-date information
on key pipeline products in the global Obesity market. It covers
emerging therapies for Obesity in active clinical development stages
including early and late stage clinical trials. The pipeline data
presented in this report helps executives in tracking competition,
identifying partners, evaluating opportunities, formulating business
development strategies, and executing in-licensing and out-licensing
deals.

Clinical Trial Stages:

The report provides Obesity pipeline products by clinical trial stages
including both early and late stage development – phase 3 clinical
trials, phase 2 clinical trials, phase 1 clinical trials, preclinical
research, and discovery stage.

Drug Mechanism Classes:

The report provides Obesity pipeline products by their dominant
mechanism of action/drug class. This helps executives categorize
products based on their drug class and also assess the strengths and
weaknesses of compounds.

Company:

The report provides Obesity pipeline products by the company.

Short-term Launch Highlights:

Find out which Obesity pipeline products will be launched in the US and
Ex-US to 2024.

Summary:

• Obesity phase 3 clinical trial pipeline products
• Obesity phase 2 clinical trial pipeline products
• Obesity phase 1 clinical trial pipeline products
• Obesity preclinical research pipeline products
• Obesity discovery stage pipeline products
• Obesity pipeline products short-term launch highlights

Key Topics Covered:

1. Obesity Pipeline by Stages

2. Obesity Phase 3 Clinical Trial Insights

3. Obesity Phase 2 Clinical Trial Insights

4. Obesity Phase 1 Clinical Trial Insights

5. Obesity Preclinical Research Insights

6. Obesity Discovery Stage Insights

7. Appendix

8. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/r/4vxeiq

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]

For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Related
Topics: Clinical
Trials, Anti-Obesity
Drugs